Upon the closing of the proposed transaction, the combined company will become a US-domiciled, public company ready to advance its ecosystem of health and wellness digital platforms, connected devices ...

INmune Bio Inc. (NASDAQ: INMB) (“INmune” or “the Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to ...